Michael Santoro

« Back to Faculty Directory
Former Professor
Academic Info

Ph.D., Harvard University; Public Policy


Human Rights, Ethical Leadership, Wall Street, Business Ethics, Corporate Governance, Pharmaceutical Industry Ethics, Intellectual Property, and Corporate Social Responsibility in China.


Business Govt. & Society; Ethics in Business; Ethics, Business, & Society; Law & Legal Reasoning

Michael A. Santoro is a world renowned business ethics teacher, scholar and consultant. He is a Professor of Management and Global Business at Rutgers Business School.  He holds a Ph.D. in Public Policy from Harvard University, a J.D. from New York University, and an A.B. from Oberlin College.

Prof. Santoro has served as a consultant to the Global Business Coalition on HIV/AIDS, Malaria, and Tuberculosis, helping in that capacity to design an industry-wide corporate integrity  program for companies supplying long lasting anti-malaria bednets.  He also worked with Arusha-based A to Z Corporation to design, adopt and implement one of the first business ethics code of conduct in Tanzania.  His expert testimony in the Vioxx litigation became the basis for court-ordered corporate governance reforms adopted by Merck.

He has been a visiting Professor at the Shanghai Advanced Institute of Finance and the University of Zurich, as well as an Adjunct Lecturer and a Teaching Fellow at Harvard’s John F. Kennedy School of Government where he taught ethics and economics courses.  As a Research Associate at Harvard Business School, he wrote or co-authored nearly thirty case studies and teaching notes on ethical and legal topics, including a leading case on the introduction of intellectual property into the WTO. He was an invited speaker at the American Bar Association Conference on Professionalism in the 21st Century.  He was the recipient of research grant from the Aspen Institute’s Initiative for Social Innovation through Business and he has also served as a GE Teaching Fellow at Rutgers Business School.

He serves on the Editorial Board of Business Ethics Quarterly and the Journal of Human Rights, and he is a member of the Board of Directors of the NASBA Center for the Public Trust.

Professor Santoro testified before the United States Senate Finance Committee on the human rights implications of China’s entry into the World Trade Organization.  He is a frequent featured speaker on human rights and business ethics at numerous venues, including Cornell, Columbia, Oberlin, Princeton, Redlands, Santa Clara, and Tufts , as well as at the Brookings Institution, the World Affairs Council, the Economic Strategy Institute, the Association of the Bar of the City of New York, and the Asia Society.

Prof. Santoro was a Fulbright Fellow at the University of Hong Kong during the 1993-94 academic year and he travels frequently to Asia.  In the summer, he has taught executive MBA courses in Business Strategy and Business Law in Beijing and Shanghai and at the Sinopec Management Institute.

Prior to entering academe, Santoro practiced law.  During law school he was a clerk at Skadden Arps Slate Meagher & Flom.  He was summer associate at Shearman & Sterling and an associate at Webster & Sheffield.  He has been the General Counsel of BioTechnica International in Cambridge, Massachusetts, one of the first publicly-held biotechnology companies, and of Finevest (now Interlaken Capital) in Greenwich, Connecticut, a privately held venture firm.


Business Insights

Rutgers Business School News

Professor Michael Santoro raises questions about Merck's continued marketing of NuvaRing

Wednesday, February 5, 2014

In an article for Medical Marketing and Media, Professor Santoro notes the role pharmaceutical companies have in society. "They make profits by serving patients. This role comes with many special ethical responsibilities," he writes. "One is to continually innovate safety as well as efficacy. Another is to share, not hide, scientific and medical truth with doctors and patients. Neither of these ethical responsibilities ought to be delineated by craftily drawn legal lines." More ›

TAGS: Business Insights Ethics MBA Merck Michael Santoro

Rutgers Business School News

Faculty Insight: Can a disgraced trader get a job in academia?

Wednesday, January 22, 2014

Rutgers Business School Professor Michael Santoro, who teaches ethics in business, spent part of last summer observing the federal court trial of former Goldman Sachs trader Fabrice Tourre. In a new article written for The New Yorker, Santoro contemplates the possibility that Tourre, who is working on a doctorate degree, could land a job teaching at a business school.  More ›

TAGS: Banking Business Insights Ethics Michael Santoro Rutgers Business School Wall Street

Rutgers Business School News

It may be time for Johnson & Johnson to challenge its credo...again

Tuesday, December 3, 2013

In an article published in Medical Marketing & Media, Rutgers Business School Professor Michael Santoro suggests that it may be time for Johnson & Johnson executives to challenge their credo, a statement the company says guides its decision making. "Is the Credo today a living, breathing set of values and beliefs that inspire and guide the actions of Johnson & Johnson employees or is it a set of fine sounding platitudes carved into stone that are no longer relevant to the way J&J manages and makes decisions?" Santoro writes in the piece. More ›

TAGS: Business Insights Ethics Johnson and Johnson Michael Santoro

Rutgers Business School News

Michael Santoro blog on SEC v Tourre trial picked up by The New Yorker

Wednesday, July 24, 2013

Rutgers Business School Professor Michael Santoro, a widely quoted expert on Wall Street ethics, is spending summer break studying Wall Street – and its regulators – at the federal court trial of former Goldman Sachs trader Fabrice Tourre. Now his blog has been picked up by The New Yorker. More ›

TAGS: Blogs Business Insights Ethics Expertise Management and Global Business Michael Santoro Thought Leadership Twitter Wall Street

Rutgers Business School News

Michael Santoro espouses SEC intention to require banks to admit guilt in enforcement actions

Thursday, July 18, 2013

The public is tired of checkbook justice in which Wall Street has been able to write off seemingly huge settlements as a mildly irritating cost of doing business. Earlier this month, Professor Michael Santoro, Department of Management and Global Business, and Professor Ronald Strauss, Montclair State University School of Business, blogged in the Huffington Post about the SEC stopping its long-standing practice of settling enforcement actions in a way that allows defendants to avoid either admitting or denying guilt.  More ›

TAGS: Business Insights Management and Global Business Michael Santoro

Rutgers Business School News

Businesses will pay new costs for health care reform, but they also stand to benefit

Thursday, January 24, 2013

Inside Business, the Gateway Regional Chamber of Commerce newspaper, features a new opinion piece written by Rutgers Business professor Michael Santoro on the tough decisions in store for U.S. businesses this year as they develop strategies to meet the requirements of the Affordable Care Act.  More ›

TAGS: Business Insights Health Care Michael Santoro Public Policy Thought Leadership

Rutgers Business School News

Ruling by federal appeals court creates new wrinkle for pharmaceutical industry and authorities

Monday, December 17, 2012

A decision by the U.S. Second Circuit Court of Appeals earlier this month stirred up new questions about the controversial issue of off-label marketing. Rutgers Business School Professor Michael Santoro weighed in on the uncertainty and some of the possible implications of the surprise ruling.  More ›

TAGS: Business Insights Michael Santoro Pharmaceutical Management The Blanche and Irwin Lerner Center Thought Leadership

Rutgers Business School News

Mr. President, New cabinet position unnecessary; The commerce secretary IS America's secretary of business

Monday, November 19, 2012

Professor Michael Santoro suggests that President Barack Obama may need to update the Department of Commerce's mission statement rather than adding a secretary of business to his cabinet. And appointing a new commerce secretary should be a priority as Obama enters his second term. America’s business community needs focus and leadership and a strong voice in the president’s cabinet, Santoro says. More ›

TAGS: Business Insights Management and Global Business Michael Santoro

Rutgers Business School News

Why is China's Money Dirty?

Thursday, March 17, 2011

Michael A. Santoro, Professor of Management and Global Business discusses the flow of capital from private-sector Chinese businesses and investors which poured nearly $5 billion into US firms, both large and small, in 2010. Such investments have spawned concerns that this is a move by Beijing to relocate companies to China, taking with them technology, resources and much needed US jobs. However, the most unsettling aspect of this $5 billion in-bound investment is the fact that there is such a big fuss is over such a relatively small amount of capital! $5 billion is actually a very small fraction of the more than the $1 trillion US debt China has purchased.  More ›

TAGS: Business Insights China Michael Santoro Thought Leadership